Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
07/26/2012 | US20120189717 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting |
07/26/2012 | US20120189716 Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting |
07/26/2012 | US20120189715 Compositions including beta-hydroxy-beta-methylbutyrate and uses thereof |
07/26/2012 | US20120189714 Compositions including beta-hydroxy-beta-methylbutyrate |
07/26/2012 | US20120189709 Method of using beta-hydroxy-beta-methylbutyrate to treat a condition |
07/26/2012 | US20120189704 Novel injectable chitosan mixtures forming hydrogels |
07/26/2012 | US20120189703 Enzyme Delivery Systems and Methods of Preparation and Use |
07/26/2012 | US20120189697 Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine |
07/26/2012 | US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof |
07/26/2012 | US20120189693 Oral dosage forms |
07/26/2012 | US20120189688 Carrier component and fabrication method thereof |
07/26/2012 | US20120189679 Method for coating powders |
07/26/2012 | US20120189643 Toll Like Receptor 3 Antagonists, Methods and Uses |
07/26/2012 | US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
07/26/2012 | US20120189626 Treatment of complement-associated disorders |
07/26/2012 | US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY |
07/26/2012 | US20120189611 Dipeptidyl peptidase-4 inhibitor |
07/26/2012 | US20120189605 Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof |
07/26/2012 | US20120189601 Assisted enzyme replacement therapy |
07/26/2012 | US20120189598 Oral nutritional supplement for children comprising probiotics |
07/26/2012 | US20120189542 Anti-CD19 Antibodies |
07/26/2012 | US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof |
07/26/2012 | CA2828738A1 Fused aminodihydrothiazine derivatives useful as bace inhibitors |
07/26/2012 | CA2825124A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders |
07/26/2012 | CA2824791A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
07/26/2012 | CA2824646A1 FERRIC CITRATE CONTAINING SUBSTANTIALLY NO ß-OXIDIZED IRON HYDROXIDE |
07/26/2012 | CA2824397A1 Combination of acylated glucagon analogues with insulin analogues |
07/26/2012 | CA2824344A1 Mineralocorticoid receptor antagonists |
07/26/2012 | CA2824317A1 Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia |
07/26/2012 | CA2823712A1 Apolipoprotein aiv as an antidiabetic peptide |
07/26/2012 | CA2819158A1 1,4 oxazines as bace1 and/or bace2 inhibitors |
07/26/2012 | CA2816538A1 Probiotic soft gel compositions |
07/26/2012 | CA2816094A1 Compounds and pharmaceutical compositions for uses in diabetes |
07/25/2012 | EP2479193A1 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
07/25/2012 | EP2479183A2 Polymorphs of sarsasapogenin |
07/25/2012 | EP2479175A1 Compounds and methods for treating dyslipidemia |
07/25/2012 | EP2479168A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists |
07/25/2012 | EP2478910A1 Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance |
07/25/2012 | EP2478902A1 Pharmaceutical composition for reducing weight and method for the production thereof |
07/25/2012 | EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
07/25/2012 | EP2477983A1 (4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanone compounds and their use |
07/25/2012 | EP2477977A2 Treatment for oxidative stress and/or hypertension |
07/25/2012 | EP2477700A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
07/25/2012 | EP2477639A1 Plant extract, compositons containing same, method of extraction and uses thereof |
07/25/2012 | EP2292611B1 Novel thiophenediamine derivative having urea structure |
07/25/2012 | EP2079688B1 Glucagon receptor antagonist compounds, compositions containing such compounds and their pharmaceutical use |
07/25/2012 | EP2077266B1 2-pyridinecarboxamide derivative having gk-activating activity |
07/25/2012 | EP1858541B1 Use of bmp antagonists to regulate hepcidin-mediated iron metabolism and treat iron deficiency |
07/25/2012 | EP1605897B1 Polyethelene glycol link glp-1 compounds |
07/25/2012 | EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
07/25/2012 | EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation |
07/25/2012 | EP1109453B1 Compositions and methods for treatment of mitochondrial diseases |
07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
07/25/2012 | CN102612371A Extracts, fractions and compositions comprising acetogenins and their applications |
07/25/2012 | CN102604855A Bifidobacterium longum SQS7-31, as well as preparation method and application thereof |
07/25/2012 | CN102604851A Lactococcus lactis capable of lowering cholesterol and producing extracellular polysaccharide |
07/25/2012 | CN102604797A Beautifying and detoxifying wine and its preparation method |
07/25/2012 | CN102604771A Medical wine production method |
07/25/2012 | CN102603906A Preparation method of inonotus obliquus polysaccharide aqueous solution |
07/25/2012 | CN102603894A Interferon alpha receptor 1 antibodies and their uses |
07/25/2012 | CN102603886A Mutant fibroblast growth factor and use thereof in treating endocrine diseases |
07/25/2012 | CN102603861A Tanshinone derivatives, medicine compositions thereof, and purposes thereof in medicine |
07/25/2012 | CN102603734A Protein kinase inhibitor and application thereof |
07/25/2012 | CN102603713A Chiral CB1 (cannabinoid) receptor inhibitor, and preparation method and medical application thereof |
07/25/2012 | CN102603711A Pyridine carboxamides as 11-beta-hsd1 inhibitors |
07/25/2012 | CN102603689A Norditerpenoid compound Lachnin A, and preparation method and application thereof |
07/25/2012 | CN102603685A Flavonoid fatty acid ester derivatives, preparation method and medicinal use of flavonoid fatty acid ester derivatives |
07/25/2012 | CN102603678A Diphenyl-methyl piperazine compound, preparation and use of the diphenyl-methyl piperazine compound |
07/25/2012 | CN102603677A Curcumin-4-mannich base derivative, preparation method and use of curcumin-4-mannich base derivative |
07/25/2012 | CN102603675A Piperazine compound and application thereof |
07/25/2012 | CN102603627A Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative |
07/25/2012 | CN102603575A Rhein-arginine eutectic compound, and preparation method, purification method and application thereof in preparation of medicines for treating diabetic complications |
07/25/2012 | CN102603519A Kaurene diterpene derivative, medicinal composition thereof and application of kaurene diterpene derivative to medicament |
07/25/2012 | CN102603396A Preparation of chitosamine-selenium nanometer trace-element nutrition regulator |
07/25/2012 | CN102600705A Edible plant dryer |
07/25/2012 | CN102600482A Applications of ssc-miR-374b-5p in preparation of drugs for reducing fat deposition and/or resisting fat-related diseases |
07/25/2012 | CN102600438A Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease |
07/25/2012 | CN102600421A Preparation process of amomum tsao-ko volatile oil hydroxypropyl-beta-cyclodextrin inclusion compound |
07/25/2012 | CN102600401A Formula of liposuction slimming hot-compress weight-losing traditional Chinese medicine bag and preparation method thereof |
07/25/2012 | CN102600384A Bamboo shoot product for treating diabetes mellitus and preparation method thereof |
07/25/2012 | CN102600349A Health-promoting composition and its application |
07/25/2012 | CN102600314A Traditional Chinese medicine coptis powder for treating diabetes mellitus |
07/25/2012 | CN102600294A Novel process for extracting pepper phospholipid from pepper |
07/25/2012 | CN102600245A Purification method and application of water-soluble alkaloid with alpha-glycosidase activity inhibition function in mulberry branch bark |
07/25/2012 | CN102600231A Anti-fatigue nutrient and preparation method thereof |
07/25/2012 | CN102600230A Application of astragalus extract |
07/25/2012 | CN102600228A Method for preparing gypenoside in gypenoside grains |
07/25/2012 | CN102600227A Compound functional red rice capsule |
07/25/2012 | CN102600214A Method for extracting leaf of Chinese ilex of broadleaf holly leaf, total saponin and application thereof |
07/25/2012 | CN102600213A Effective antioxidation method for ganoderma lucidum spore powder |
07/25/2012 | CN102600202A Promoter for recovery from anesthesia |
07/25/2012 | CN102600201A Pharmaceutical composition for relaxing bowels and purging intestines and preparation method of pharmaceutical composition |
07/25/2012 | CN102600189A Application of ginseng secondary saponin and aliphatic ester derivative thereof in preventing and treating diabetes mellitus |
07/25/2012 | CN102600187A Amino acid and glucose injection packaged by dual-chambered bag, and preparation method of the injection |
07/25/2012 | CN102600171A Structure utilizing benzothiadiazine and pyrazolothiadiazine derivatives as aldose reductase inhibitor, synthetic method and application |
07/25/2012 | CN102600165A Application of compound alfuzosin hydrochloride in preparing information therapy medicines, preparation method thereof and prepared novel medicine |
07/25/2012 | CN102600162A Pyridazine derivatives and their use as therapeutic agents |
07/25/2012 | CN102600149A Pharmaceutical composition for treating diabetes |
07/25/2012 | CN102600144A Roflumilast for the treatment of diabetes mellitus |
07/25/2012 | CN102600139A Medicinal composition containing 20 kinds of amino acids |